Foveal atrophy in patients with active central serous chorioretinopathy at first presentation: characteristics and treatment outcomes.

CSC with foveal atrophy was associated with a shallow SRF height, low treatment efficacy and poor vision before and after treatment. We suggest that early active treatment should be considered for eyes with CSC accompanied by a persistent shallow SRF and foveal atrophy.